You are on page 1of 18

Dr. A.

Castro Silva
Clinical Fellow
University Hospital Southampton

UK/CORP/0415/0049d October 2017


Conflicts of Interest
Nil
ASE
Joint working project between IBD Registry,
Pharmacosmos and BSG.

2014 National IBD audit highlighted under-


treatment of IDA.
National IBD Audit
Chronic fatigue is common in IBD
IDA is one of the primary causes
Significant impact on QOL

49% and 47% admitted with UC were


anaemic.
56% did not receive treatment.
Aims of ASE
1. Establish the number of IBD outpatients with
IDA.

2. Observe the type of treatment they receive.

Improve treatment outcomes of IBD


patients with IDA.
First ever UK wide repository of anonymised IBD
patient data.

Clinical summary

Demographics

Disease Classification and scores


Hb
MCV
Ferritin
CRP
Iron Studies, Folate, B12

Iron Treatment
Disease Activity
Mean age 44 years 11 months (19 90 years)

Disease activity scores (70 patients)


Mean HBI: 3.7 (55 pt)
Mean UCDAI: 2.4 (13 pt)
Disease Activity
Mean age 44 years 11 months (19 90 years)

Disease activity scores (70 patients)


Mean HBI: 3.7 (55 pt)
Mean UCDAI: 2.4 (13 pt)
Severe

Physicians Global Assessment


Moderate

Mild
Quiescent
Anaemia
22/92 (24%) patients were anaemic

CD (n=50): Mean Hb 132.8 g/L


14/50 (28%) anaemic
14/50 (28%) iron deficient

UC (n=42): Mean Hb 137.5 g/L


7/42 (16%) anaemic
14/42 (33%) iron deficient
Symptoms
52 patients reported fatigue
64.3% anaemic, 54.2% non-anaemic patients

26 missed activities

IBD Control 8 Score (0-16) was similar in both


anaemic and non-anaemic patients (11.47,
11.45, respectively).
Conclusion
IBD Registry and ASE are easy to use online tools.

Reliable method of capturing quality improvement


data.
Prevalence, impact and treatment of IDA in IBD can
be efficiently assessed.
Improve patient care in a population with high
occurrence of anaemia.
Any Questions?
Thank you